Atıf Formatları
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Z. Kalkan Et Al. , "Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study," Medicina (Lithuania) , vol.61, no.4, 2025

Kalkan, Z. Et Al. 2025. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina (Lithuania) , vol.61, no.4 .

Kalkan, Z., Ebinç, S., Arcagok, M., BİLİCİ, A., YILDIZ, Ö., Kilickap, S., ... GÜVEN, D. C.(2025). Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina (Lithuania) , vol.61, no.4.

Kalkan, Ziya Et Al. "Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study," Medicina (Lithuania) , vol.61, no.4, 2025

Kalkan, Ziya Et Al. "Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study." Medicina (Lithuania) , vol.61, no.4, 2025

Kalkan, Z. Et Al. (2025) . "Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study." Medicina (Lithuania) , vol.61, no.4.

@article{article, author={Ziya Kalkan Et Al. }, title={Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study}, journal={Medicina (Lithuania)}, year=2025}